Imaging the tumor microenvironment

Cancer Journal (United States)

Volumn 21, Issue 3, 2015, Pages 174-178

  Lebleu, Valerie S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Angiogenesis; cancer associated fibroblasts; extracellular matrix; imaging; tumor microenvironment

Indexed keywords

ANGIOGENESIS; BLOOD FLOW; CANCER GROWTH; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; STROMA CELL; TUMOR MICROENVIRONMENT; DIAGNOSTIC IMAGING; DISEASE COURSE; GENETICS; MOLECULAR IMAGING; NEOPLASM; PATHOLOGY; RADIOGRAPHY;

DISEASE PROGRESSION; HUMANS; MOLECULAR IMAGING; NEOPLASMS; RADIOGRAPHY; TUMOR MICROENVIRONMENT;

EID: 84930583062     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000118     Document Type: Review

References (41)

1. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009; 26:1216-1219.
2. Hynes RO, Naba A. Overview of the matrisome-an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4:a004903.
3. Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast. 2013;22(suppl 2): S66-S72.
4. Cretu A, Brooks PC. Impact of the non-cellular tumor microenvironment on metastasis: potential therapeutic and imaging opportunities. J Cell Physiol. 2007;213:391-402.
5. Maeshima Y, Colorado PC, Torre A, et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem. 2000;275:21340-21348.
6. Kamphaus GD, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem. 2000;275:1209-1215.
7. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52-67.
8. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol. 2011;21:228-237.
9. Neesse A, Michl P, Frese KK, et al. Stromal biology and therapy in pancreatic cancer. Gut. 2011;60:861-868.
10. Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol. 2010;2:a003244.
11. Conklin MW, Keely PJ. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adh Migr. 2012;6:249-260.
12. Dittmer J, Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin Cancer Biol. 2015;31C:3-15.
13. Thompson RF, Maity A. Radiotherapy and the tumor microenvironment: mutual influence and clinical implications. Adv Exp Med Biol. 2014;772:147-165.
14. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98-101.
15. Langley RR, Fidler IJ. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527-2535.
16. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56-61.
17. Paulmurugan R, Oronsky B, Brouse CF, et al. Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm. Theranostics. 2013;3:437-447.
18. Serres S, O'Brien ER, Sibson NR. Imaging angiogenesis, inflammation, and metastasis in the tumor microenvironment with magnetic resonance imaging. Adv Exp Med Biol. 2014;772:263-283.
19. Wu Y, Zhang W, Li J, et al. Optical imaging of tumor microenvironment. Am J Nucl Med Mol Imaging. 2013;3:1-15.
20. Avni R, Cohen B, Neeman M. Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed. 2011;24:569-581.
21. Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med. 2008;49(suppl 2):129S-148S.
22. Matsuo M, Matsumoto S, Mitchell JB, et al. Magnetic resonance imaging of the tumor microenvironment in radiotherapy: perfusion, hypoxia, and metabolism. Semin Radiat Oncol. 2014;24:210-217.
23. Rajendran JG, Krohn KA. F-18 Fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. Semin Nucl Med. 2015;45:151-162.
24. Hashim AI, Zhang X, Wojtkowiak JW, et al. Imaging pH and metastasis. NMR Biomed. 2011;24:582-591.
25. Penet MF, Chen Z, Bhujwalla ZM.MRI of metastasis-permissive microenvironments. Future Oncol. 2011;7:1269-1284.
26. Glunde K, Bhujwalla ZM. Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol. 2011;38:26-41.
27. Penet MF, Glunde K, Jacobs MA, et al. Molecular and functional MRI of the tumor microenvironment. J NuclMed. 2008;49:687-690.
28. SuetsuguA, KatzM, Fleming J, et al.Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens. J Cell Biochem. 2012;113:2290-2295.
29. Sidani M, Wyckoff J, Xue C, et al. Probing the microenvironment of mammary tumors using multiphoton microscopy. J Mammary Gland Biol Neoplasia. 2013;11:151-163.
30. Zal T, Chodaczek G. Intravital imaging of anti-tumor immune response and the tumor microenvironment. Semin Immunopathol. 2010;32:305-317.
31. Nakasone ES, Askautrud HA, Egeblad M. Live imaging of drug responses in the tumor microenvironment in mouse models of breast cancer. J Vis Exp. 2013: e50088.
32. Gligorijevic B, Bergman A, Condeelis J. Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol. 2014;12:e1001995.
33. Nakasone ES, Askautrud HA, Kees T, et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012;21:488-503.
34. Histed SN, LindenbergML, Mena E, et al. Reviewof functional/anatomical imaging in oncology. Nucl Med Commun. 2012;33:349-361.
35. Stasinopoulos I, Penet MF, Chen Z, et al. Exploiting the tumor microenvironment for theranostic imaging. NMR Biomed. 2011;24:636-647.
36. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl JMed. 1986;315:1650-1659.
37. Ozdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinomaassociated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719-734.
38. Rhim AD, Oberstein PE, Thomas DH, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735-747.
39. CookeVG, LeBleuVS, KeskinD, et al. Pericyte depletion results in hypoxiaassociated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell. 2012;21:66-81.
40. KeskinD, Kim J, CookeVG, et al. Targeting vascular pericytes in hypoxic tumors increases lungmetastasis via angiopoietin-2. Cell Rep. 2015;10:1066-1081.
41. Choi IK, Strauss R, Richter M, et al. Strategies to increase drug penetration in solid tumors. Front Oncol. 2013;3:193.